Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such... Curr Diab Rep (2017) 17: 128 https://doi.org/10.1007/s11892-017-0967-z PHARMACOLOGIC TREATMENT OF TYPE 2 DIABETES (HE LEBOVITZ AND G BAHTIYAR, SECTION EDITORS) Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications? 1 2,3 1,4,5 1,4,6 Magnus F. Grøndahl & Damien J. Keating & Tina Vilsbøll & Filip K. Knop Published online: 28 October 2017 Springer Science+Business Media, LLC 2017 Abstract underestimated role in the efficacy and safety of several Purpose of Review Hyperglucagonemia contributes signifi- glucose-lowering drugs. cantly to hyperglycemia in type 2 diabetes and suppressed Summary Numerous drugs currently available to diabetologists glucagon levels may increase the risk of hypoglycemia. are capable of altering glucagon secretion: metformin, sulfonyl- Here, we give a brief overview of glucagon physiology and urea compounds, insulin, glucagon-like peptide-1 receptor ago- the role of glucagon in the pathophysiology of type 2 diabetes nists, dipeptidyl peptidase-4 inhibitors, sodium-glucose and provide insights into how antidiabetic drugs influence cotransporter 2 inhibitors and amylin mimetics. Their diverse glucagon secretion as well as a perspective on the future of effects on glucagon secretion are of importance for their indi- glucagon-targeting drugs. vidual efficacy and safety profiles. Understanding how these Recent Findings Several older as well as http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Diabetes Reports Springer Journals

Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

Loading next page...
 
/lp/springer_journal/current-therapies-that-modify-glucagon-secretion-what-is-the-oCnRgjhv06
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Diabetes
ISSN
1534-4827
eISSN
1539-0829
D.O.I.
10.1007/s11892-017-0967-z
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial